Prestige Consumer Healthcare Inc. (PBH)
USD 78.79
(-1.99%)
USD 78.79
(-1.99%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 1.09 Billion USD | -16.46% |
| 2023 | 1.3 Billion USD | -11.53% |
| 2022 | 1.47 Billion USD | -0.21% |
| 2021 | 1.48 Billion USD | -11.34% |
| 2020 | 1.67 Billion USD | -5.6% |
| 2019 | 1.77 Billion USD | -9.66% |
| 2018 | 1.96 Billion USD | -8.9% |
| 2017 | 2.15 Billion USD | 34.65% |
| 2016 | 1.59 Billion USD | 1.96% |
| 2015 | 1.56 Billion USD | 72.99% |
| 2014 | 906.08 Million USD | -5.15% |
| 2013 | 955.23 Million USD | -13.55% |
| 2012 | 1.1 Billion USD | 133.29% |
| 2011 | 473.61 Million USD | 67.33% |
| 2010 | 283.04 Million USD | -17.52% |
| 2009 | 343.15 Million USD | -15.3% |
| 2008 | 405.14 Million USD | -9.89% |
| 2007 | 449.59 Million USD | -8.33% |
| 2006 | 490.43 Million USD | 0.08% |
| 2005 | 490.02 Million USD | 237.25% |
| 2004 | 145.3 Million USD | 4216.18% |
| 2003 | -3.53 Million USD | 55.23% |
| 2002 | -7.88 Million USD | 0.0% |
| 2001 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | 1.09 Billion USD | -16.46% |
| 2024 Q4 | 1.09 Billion USD | -4.93% |
| 2024 Q1 | 1.28 Billion USD | -2.13% |
| 2024 Q2 | 1.21 Billion USD | -4.79% |
| 2024 Q3 | 1.14 Billion USD | -5.7% |
| 2023 Q4 | 1.3 Billion USD | -3.87% |
| 2023 Q3 | 1.36 Billion USD | -4.21% |
| 2023 Q2 | 1.42 Billion USD | -2.93% |
| 2023 Q1 | 1.46 Billion USD | -1.02% |
| 2023 FY | 1.3 Billion USD | -11.53% |
| 2022 Q3 | 1.54 Billion USD | -3.0% |
| 2022 Q2 | 1.58 Billion USD | 12.27% |
| 2022 Q1 | 1.41 Billion USD | -4.56% |
| 2022 Q4 | 1.47 Billion USD | -3.99% |
| 2022 FY | 1.47 Billion USD | -0.21% |
| 2021 Q2 | 1.56 Billion USD | -2.32% |
| 2021 FY | 1.48 Billion USD | -11.34% |
| 2021 Q1 | 1.59 Billion USD | -4.45% |
| 2021 Q4 | 1.48 Billion USD | -2.69% |
| 2021 Q3 | 1.52 Billion USD | -2.38% |
| 2020 Q2 | 1.76 Billion USD | -0.41% |
| 2020 Q4 | 1.67 Billion USD | -2.3% |
| 2020 FY | 1.67 Billion USD | -5.6% |
| 2020 Q1 | 1.76 Billion USD | -0.18% |
| 2020 Q3 | 1.71 Billion USD | -2.81% |
| 2019 Q1 | 1.95 Billion USD | -0.04% |
| 2019 Q2 | 1.85 Billion USD | -5.13% |
| 2019 Q3 | 1.81 Billion USD | -2.22% |
| 2019 FY | 1.77 Billion USD | -9.66% |
| 2019 Q4 | 1.77 Billion USD | -2.56% |
| 2018 Q1 | 2.1 Billion USD | -2.35% |
| 2018 FY | 1.96 Billion USD | -8.9% |
| 2018 Q4 | 1.96 Billion USD | -2.37% |
| 2018 Q3 | 2 Billion USD | -2.01% |
| 2018 Q2 | 2.04 Billion USD | -2.48% |
| 2017 FY | 2.15 Billion USD | 34.65% |
| 2017 Q4 | 2.15 Billion USD | 59.13% |
| 2017 Q3 | 1.35 Billion USD | -6.69% |
| 2017 Q2 | 1.44 Billion USD | -6.41% |
| 2017 Q1 | 1.54 Billion USD | -3.1% |
| 2016 Q3 | 1.39 Billion USD | -3.56% |
| 2016 Q2 | 1.44 Billion USD | -2.93% |
| 2016 FY | 1.59 Billion USD | 1.96% |
| 2016 Q4 | 1.59 Billion USD | 14.31% |
| 2016 Q1 | 1.49 Billion USD | -4.72% |
| 2015 Q2 | 1.67 Billion USD | 75.13% |
| 2015 Q1 | 953.88 Million USD | 5.28% |
| 2015 Q4 | 1.56 Billion USD | -3.01% |
| 2015 FY | 1.56 Billion USD | 72.99% |
| 2015 Q3 | 1.61 Billion USD | -3.27% |
| 2014 Q3 | 935.44 Million USD | -1.72% |
| 2014 Q1 | 933.93 Million USD | -2.23% |
| 2014 Q2 | 951.86 Million USD | 1.92% |
| 2014 FY | 906.08 Million USD | -5.15% |
| 2014 Q4 | 906.08 Million USD | -3.14% |
| 2013 Q2 | 1.05 Billion USD | -3.77% |
| 2013 FY | 955.23 Million USD | -13.55% |
| 2013 Q4 | 955.23 Million USD | -3.5% |
| 2013 Q3 | 989.86 Million USD | -5.79% |
| 2013 Q1 | 1.09 Billion USD | -1.18% |
| 2012 Q1 | 458.18 Million USD | -3.26% |
| 2012 FY | 1.1 Billion USD | 133.29% |
| 2012 Q3 | 425.19 Million USD | -3.24% |
| 2012 Q2 | 439.44 Million USD | -4.09% |
| 2012 Q4 | 1.1 Billion USD | 159.86% |
| 2011 Q2 | 236.81 Million USD | -9.86% |
| 2011 Q1 | 262.71 Million USD | -7.18% |
| 2011 FY | 473.61 Million USD | 67.33% |
| 2011 Q4 | 473.61 Million USD | 12.51% |
| 2011 Q3 | 420.95 Million USD | 77.76% |
| 2010 Q1 | 325.18 Million USD | -5.24% |
| 2010 FY | 283.04 Million USD | -17.52% |
| 2010 Q4 | 283.04 Million USD | -0.71% |
| 2010 Q3 | 285.07 Million USD | -6.07% |
| 2010 Q2 | 303.5 Million USD | -6.67% |
| 2009 Q4 | 343.15 Million USD | -3.72% |
| 2009 FY | 343.15 Million USD | -15.3% |
| 2009 Q1 | 389.85 Million USD | -3.77% |
| 2009 Q2 | 372.59 Million USD | -4.43% |
| 2009 Q3 | 356.4 Million USD | -4.35% |
| 2008 Q2 | 428.31 Million USD | -2.94% |
| 2008 FY | 405.14 Million USD | -9.89% |
| 2008 Q1 | 441.29 Million USD | -1.84% |
| 2008 Q4 | 405.14 Million USD | -2.3% |
| 2008 Q3 | 414.67 Million USD | -3.19% |
| 2007 Q4 | 449.59 Million USD | -3.61% |
| 2007 Q2 | 479.25 Million USD | 2.14% |
| 2007 FY | 449.59 Million USD | -8.33% |
| 2007 Q1 | 469.23 Million USD | -4.32% |
| 2007 Q3 | 466.43 Million USD | -2.68% |
| 2006 Q2 | 465.91 Million USD | -3.03% |
| 2006 FY | 490.43 Million USD | 0.08% |
| 2006 Q1 | 480.48 Million USD | -1.95% |
| 2006 Q4 | 490.43 Million USD | -3.44% |
| 2006 Q3 | 507.91 Million USD | 9.02% |
| 2005 Q3 | 673.53 Million USD | 0.0% |
| 2005 Q4 | 490.02 Million USD | -27.25% |
| 2005 FY | 490.02 Million USD | 237.25% |
| 2004 FY | 145.3 Million USD | 4216.18% |
| 2003 FY | -3.53 Million USD | 55.23% |
| 2002 FY | -7.88 Million USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Cardinal Health, Inc. | 476 Million USD | -129.661% |
| Cencora | 2.19 Billion USD | 50.206% |
| McKesson Corporation | 2.8 Billion USD | 61.027% |
| Owens & Minor, Inc. | 2.07 Billion USD | 47.364% |